Our findings contrast with previous studies in vitro, which demonstrated that ectopic expression of TFPI-2 significantly inhibited cell proliferation in hepatocellular carcinoma [11], nasopharyngeal carcinoma [10] cell lines and Human retinal endothelial cells [32]. This evidence concerns the gene TFPI2 and nasopharyngeal carcinoma.